Association of prescription drug monitoring programs with benzodiazepine prescription dispensation and overdose in adolescents and young adults

被引:1
|
作者
Toce, Michael S. S. [1 ,2 ,3 ,6 ]
Michelson, Kenneth A. A. [1 ,3 ]
Hudgins, Joel D. D. [1 ,3 ]
Olson, Karen L. L. [3 ,4 ]
Monuteaux, Michael C. C. [1 ]
Bourgeois, Florence T. T. [1 ,3 ,5 ]
机构
[1] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Harvard Med Toxicol Program, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA USA
[4] Boston Childrens Hosp, Computat Hlth Informat Program CHIP, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Computat Hlth Informat Program CHIP, Pediat Therapeut & Regulatory Sci Initiat, Boston, MA 02115 USA
[6] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA
关键词
Benzodiazepine; overdose; prescription drug misuse; adolescents; prescription drug monitoring program; STATES; REDUCE; LAWS;
D O I
10.1080/15563650.2023.2181092
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
IntroductionPrescription drug monitoring programs are state-run databases designed to support safe prescribing of controlled substances and reduce prescription drug misuse. We analyzed healthcare claims data to determine the association between prescription drug monitoring programs with mandated provider review and adolescent and young adult benzodiazepine prescription dispensing and overdose.MethodsWe performed a state-level retrospective cohort study to evaluate the association between implementation of prescription drug monitoring programs with mandated provider review and benzodiazepine prescription dispensing and benzodiazepine-related overdoses among adolescents (13-18 years) and young adults (19-25 years) between 1 January 2008 and 31 December 2019. Data were obtained from a United States commercial health insurance company.ResultsThere were 74,539 (1.8%) adolescents and 246,760 (4.0%) young adults with at least one benzodiazepine prescription dispensed. Benzodiazepine overdoses occurred among 1,569 (0.04%) and 3,202 (0.05%) adolescents and young adults, respectively. Implementation of a prescription drug monitoring program with mandated provider review was associated with a 6.8% (95% CI, 1.6-11.8) yearly reduction in benzodiazepine prescription dispensing among adolescents and a 12.5% (95% CI, 9.3-15.5) yearly reduction among young adults. There was no decrease in benzodiazepine overdoses in either age group (-15.4% [95% CI, -21.5 to 3.0] and -8.0% [95% CI, -18.0 to 3.2] yearly change in adolescents and young adults, respectively).DiscussionConsistent with prior work, our study did not find an association between prescription drug monitoring program implementation and reduction in benzodiazepine-related overdoses among adolescents and young adults. However, the substantial reduction in benzodiazepine prescription dispensing is encouraging.ConclusionPrescription drug monitoring programs were associated with decreases in benzodiazepine prescription dispensing, but not benzodiazepine-related overdoses in this cohort of adolescents and young adults. These findings serve to inform development of further policies to address rising rates of benzodiazepine misuse and overdose in this patient population.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 50 条
  • [31] State Prescription Drug Monitoring Programs and Fatal Drug Overdoses
    Nam, Young Hee
    Shea, Dennis G.
    Shi, Yunfeng
    Moran, John R.
    AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (05): : 297 - U131
  • [32] Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses A Systematic Review
    Fink, David S.
    Schleimer, Julia P.
    Sarvet, Aaron
    Grover, Kiran K.
    Delcher, Chris
    Castillo-Carniglia, Alvaro
    Kim, June H.
    Rivera-Aguirre, Ariadne E.
    Henry, Stephen G.
    Martins, Silvia S.
    Cerda, Magdalena
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (11) : 783 - +
  • [33] Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States
    Puac-Polanco, Victor
    Chihuri, Stanford
    Fink, David S.
    Cerda, Magdalena
    Keyes, Katherine M.
    Li, Guohua
    EPIDEMIOLOGIC REVIEWS, 2020, 42 (01) : 134 - 153
  • [34] Interprofessional education workshop for prescription drug monitoring programs
    Howard, Mitchell S.
    Bodi, Shirley M.
    Peeters, Michael J.
    MEDICAL EDUCATION, 2023, 57 (11) : 1161 - 1162
  • [35] Prescription drug monitoring programs in the United States of America
    Felix, Sausan El Burai
    Mack, Karin
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (04): : 270 - 276
  • [36] Research to support optimization of prescription drug monitoring programs
    Doyle, Sheri
    Leichtling, Gillian
    Hildebran, Christi
    Reilly, Cynthia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (11) : 1425 - 1427
  • [37] Perceived Unintended Consequences of Prescription Drug Monitoring Programs
    Lai, Alden Yuanhong
    Smith, Katherine C.
    Vernick, Jon S.
    Davis, Corey S.
    Alexander, G. Caleb
    Rutkow, Lainie
    SUBSTANCE USE & MISUSE, 2019, 54 (02) : 345 - 349
  • [38] Community Pharmacist Involvement in Prescription Drug Monitoring Programs
    Doong, Katie S.
    Gaccione, Daniella M.
    Brown, Todd A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (06) : 227 - 229
  • [39] EFFECT OF PRESCRIPTION DRUG MONITORING PROGRAMS ON TESTOSTERONE PRESCRIPTIONS
    Mulloy, E.
    Eisenberg, M.
    Li, S.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S122 - S122
  • [40] Prescription drug monitoring programs, opioid abuse, and crime
    Dave, Dhaval
    Deza, Monica
    Horn, Brady
    SOUTHERN ECONOMIC JOURNAL, 2021, 87 (03) : 808 - 848